SHE:002603

4 stories mentioning SHE:002603Updated just now

Every FINWIRES story that references SHE:002603, newest first.

Yiling Pharmaceutical's Letrozole API Gets EU Drug Regulator's Certificate of Suitability

Shijiazhuang Yiling Pharmaceutical (SHE:002603) through unit Wanyang Hengshui Pharmaceutical, received a certificate of suitability from the European Union's pharmaceutical regulator for the active pharmaceutical ingredient, Letrozole, according to a Thursday filing on the Shenzhen bourse.The API, which inhibits estrogen synthesis, is used in the treatment of breast cancer.The Chinese pharmaceutical company's shares rose 1% at the close.

SHE:002603

Asia14d ago

China's Drug Regulator Accepts Yiling Pharma's Clinical Trial Application for LB220-D08 Tablets; Shares Up 3%

China's National Medical Products Administration accepted Shijiazhuang Yiling Pharmaceutical's (SHE:002603) clinical trial application for LB220-D08 extended-release tablets, according to a Shenzhen bourse filing on Thursday.The drug will be tested as a treatment for atypical hemolytic uremic syndrome.The pharmaceutical company's shares rose 3% in the afternoon trade.

SHE:002603

Asia58d ago

Shijiazhuang Yiling Pharmaceutical Subsidiary Gets China Nod for Erectile Dysfunction Drug

Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Yiling Wanzhou International Pharmaceutical obtained Chinese approval for its tadalafil tablets, according to a Saturday filing with the Shenzhen bourse.The drug is a PDE5 inhibitor, indicated for erectile dysfunction.

SHE:002603

Asia103d ago

Shijiazhuang Yiling Pharmaceutical Gets China Approval for Influenza Tablets

China's drug regulator approved the marketing application for oseltamivir phosphate produced by Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Wanyang Hengshui Pharmaceutical, according to a Friday stock disclosure in Shenzhen.The drug helps treat influenza A and B.

SHE:002603

Track with the FINWIRES app suite

FolioX

Track SHE:002603 in your portfolio

WheelAI

Analyze SHE:002603 options with the wheel strategy

StockInsider

See market sentiment on SHE:002603